A Phase 2 Study of IkT-148009 in Untreated Parkinson¿s Disease
Clinical Trial Grant
Administered By
Neurology, Movement Disorders
Awarded By
Inhibikase Therapeutics, Inc.
Start Date
November 22, 2022
End Date
September 1, 2024
Administered By
Neurology, Movement Disorders
Awarded By
Inhibikase Therapeutics, Inc.
Start Date
November 22, 2022
End Date
September 1, 2024